Featured
Health Topics
- Analytical, Diagnostic and Therapeutic Techniques and Equipment27 See more
-
Chemicals and Drugs218
See more
- Amino Acids, Peptides, and Proteins 58
- Biological Factors 16
- Biomedical and Dental Materials 1
- Carbohydrates 10
- Chemical Actions and Uses 39
- Complex Mixtures 20
- Enzymes and Coenzymes 4
- Heterocyclic Compounds 67
- Hormones, Hormone Substitutes, and Hormone Antagonists 18
- Inorganic Chemicals 33
- Lipids 4
- Macromolecular Substances 1
- Nucleic Acids, Nucleotides, and Nucleosides 5
- Organic Chemicals 104
- Pharmaceutical Preparations 6
- Polycyclic Compounds 33
-
Diseases436
See more
- Bacterial Infections and Mycoses 35
- Cardiovascular Diseases 45
- Chemically-Induced Disorders 28
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities 54
- Digestive System Diseases 37
- Endocrine System Diseases 46
- Eye Diseases 7
- Female Urogenital Diseases and Pregnancy Complications 36
- Hemic and Lymphatic Diseases 38
- Immune System Diseases 61
- Male Urogenital Diseases 34
- Musculoskeletal Diseases 15
- Neoplasms 83
- Nervous System Diseases 69
- Nutritional and Metabolic Diseases 80
- Otorhinolaryngologic Diseases 11
- Parasitic Diseases 10
- Pathological Conditions, Signs and Symptoms 150
- Respiratory Tract Diseases 19
- Skin and Connective Tissue Diseases 18
- Stomatognathic Diseases 8
- Virus Diseases 40
- Wounds and Injuries 8
- Health Care2 See more
- Phenomena and Processes36 See more
- Psychiatry and Psychology71 See more
- Technology, Industry, Agriculture6 See more
Search Clinical Trials
Completed
Cytotoxic T-Lymphocytes for the Prophylaxis of Cytomegalovirus After Allogeneic Stem Cell Transplant (External Link)
If the patient and their donor are eligible, we will take 100-120 ml (20-24 teaspoonfuls) of blood from the donor 3-4 weeks before the transplant. We will only take as …
Baylor Role:
Lead Sponsor
Completed
Effectiveness of Intensive Lipid Modification Medication in Preventing the Progression of Peripheral Arterial Disease (The ELIMIT Study) (External Link)
PAD occurring in the legs is a serious disease that affects about 8 million people in the United States. A person's risk for PAD increases with age but can also …
Baylor Role:
Lead Sponsor
Completed
Treating Late-Life Generalized Anxiety Disorder (GAD) in Primary Care (External Link)
Generalized Anxiety Disorder (GAD) is one of the most common anxiety disorders among older adults. Anxiety in older adults is associated with decreased physical activity, poorer self-perceptions of health, decreased …
Baylor Role:
Lead Sponsor
Completed
Prevention of Urinary Tract Infection (UTI) in Persons With Spinal Cord Injury (SCI) (External Link)
This clinical trial will be take place in a total of 7 medical centers that care for Spinal cord injury (SCI) and Spina Bifida patients. A total of 160 patients …
Baylor Role:
Lead Sponsor
Completed
Compassionate Use of Nitazoxanide for the Treatment of Clostridium Difficile Infection (External Link)
Clostridium difficile is the leading cause of nosocomial diarrheal disease associated with antibiotic therapy. This is a debilitating condition with substantial morbidity and a mortality that may be around 2-3%. …
Baylor Role:
Collaborator
Completed
Diet, Exercise, Niacin, and Fenofibrate to Reduce Heart Disease Risk Factors in Individuals With HIV Lipodystrophy or Dyslipidemia (External Link)
BACKGROUND: HIV lipodystrophy syndrome is associated with both metabolic (e.g., dyslipidemia and insulin resistance) and anthropomorphic (e.g., lipoatrophy and central obesity) abnormalities. These defects are likely to predispose HIV patients …
Baylor Role:
Lead Sponsor
Completed
Pulmonary Infections Masquerading as Community-Acquired Pneumonia (External Link)
Guidelines to treat community acquired pneumonia (CAP) have been developed and widely promulgated by important professional societies in the past 10 years. The impetus to do so came from the …
Baylor Role:
Collaborator
Completed
Hospital-based Paraprofessional Lactation Clinic (External Link)
Methods: Eligibility: Hispanic mothers who intended to breastfeed and were scheduled for simultaneous discharge with their healthy infants were eligible for enrollment. Women were excluded if factors indicating elevated risk …
Baylor Role:
Lead Sponsor
Completed
The Effect of Prolonged Pramlintide Infusion in Pediatric Diabetes (External Link)
The Diabetes Control and Complications Trial (DCCT) showed that improving blood sugar control for individuals with Type 1 diabetes (T1DM) stopped or delayed the onset of long-term complications. As a …
Baylor Role:
Lead Sponsor
Completed
EBV-Specific CTLs Following CD45 Antibody to Patients With Epstein-Barr Virus (EBV) + Nasopharyngeal Carcinoma (NPC) (External Link)
Three different doses of CTL will be evaluated: dose level I: 2 x 10e7/m2; dose level II: 5 x 10e7/m2; dose level III: 1 x 10e8/m2 Day 1 YTH 24/54 …
Baylor Role:
Lead Sponsor